Byung Hak Jin

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Emergency Department

Allergic Rhinitis

Molecular Dynamics

Top Venues

Therapeutics and clinical risk management

Translational and clinical pharmacology

Clinical and translational science

This page only lists publications with an associated author ORCID identifier.

Publications

Sukyong Yoon, Byung Hak Jin, Choon-Ok Kim, Kyung-Soo Park, Min Soo Park, Dongwoo Chae
Pharmacokinetic Modeling of Bepotastine for Determination of Optimal Dosage Regimen in Pediatric Patients with Allergic Rhinitis or Urticaria. Pharmaceutics 16 (3) (2024)
Yun Seob Jung, Byung Hak Jin, Ju Eun Choi, Min Soo Park, Young-Woo Kim, Hyung Won Kang, Sunyoung Cho, Choon Ok Kim
Assessment of Pharmacokinetic Effects of Herbal Medicines on Escitalopram. Therapeutics and clinical risk management 20 (2024)
Sukyong Yoon, Byung Hak Jin, Choon-Ok Kim, Kyung-Soo Park, Min Soo Park, Dongwoo Chae
Pharmacokinetic Modeling of Bepotastine for Determination of Optimal Dosage Regimen in Pediatric Patients with Allergic Rhinitis or Urticaria. Pharmaceutics 16 (3) (2024)
Sukyong Yoon, Byung Hak Jin, Choon-Ok Kim, Kyung-Soo Park, Min Soo Park, Dongwoo Chae
Pharmacokinetic Modeling of Bepotastine for Determination of Optimal Dosage Regimen in Pediatric Patients with Allergic Rhinitis or Urticaria. Pharmaceutics 16 (3) (2024)
Yun Seob Jung, Byung Hak Jin, Ju Eun Choi, Min Soo Park, Young-Woo Kim, Hyung Won Kang, Sunyoung Cho, Choon Ok Kim
Assessment of Pharmacokinetic Effects of Herbal Medicines on Escitalopram. Therapeutics and clinical risk management 20 (2024)
Dasohm Kim, Minkyu Choi, Byung Hak Jin, Taegon Hong, Choon Ok Kim, Byung Won Yoo, Min Soo Park
Pharmacokinetic and Pharmacodynamic Drug-Drug Interactions between Evogliptin and Empagliflozin or Dapagliflozin in Healthy Male Volunteers. Clinical and translational science (2023)
Heeyoung Kim, Choon-Ok Kim, Hyeonsoo Park, Min Soo Park, Dasohm Kim, Taegon Hong, Yesong Shin, Byung Hak Jin
Evaluation of pharmacokinetic interactions between lobeglitazone, empagliflozin, and metformin in healthy subjects. Translational and clinical pharmacology 31 (1) (2023)
Taegon Hong, Byung Hak Jin, Choon Ok Kim, Byung Won Yoo, Dasohm Kim, Jung Il Lee, Beom Kyung Kim, Sang Hoon Ahn, Do Young Kim, Jun Yong Park, Min Soo Park
Pharmacokinetics and safety of evogliptin in hepatically impaired patients. British journal of clinical pharmacology 87 (7) (2020)